World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Welcome to the World Journal of Gastrointestinal Oncology

Integrates data from multiple studies to show approximate timeframes for the development of key stages of the Correa cascade.

Modulation of microRNA’s dynamics in the colorectal cancer microenvironment.

Spasmolytic polypeptide-expressing metaplasia process in “paligenosis”.

Overall survival between patients with and without chemotherapy in the locally advanced gastric adenocarcinoma and the locally advanced primary gastric adenosquamous carcinoma groups.

The mechanisms of cellular-mesenchymal epithelial transition factor hyperactivation.

‹ ›

Protective effects of Butia capitata extract against colitis-driven colorectal tumorigenesis: Insights into its anti-inflammatory and antinociceptive activities

Featured Articles More >>

Protective effects of Butia capitata extract against colitis... 2026-05-14
Characteristics and prognosis of primary gastric adenosquamo... 2026-05-14
Diagnostic and prognostic values of pancreatic juice carbohy... 2026-05-14
Evolution of non-invasive colorectal neoplasm detection 2026-05-14
Inhibiting exosomal miR-191 can induce ferroptosis in macrop... 2026-05-14

JOURNAL HOME

Number of total visits: 5791952

Number of visits today: 6165

Number of downloads: 4238389

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

GUIDELINES FOR AUTHORS

World Journal of Gastrointestinal Oncology is an international, peer-reviewed, open-access academic journal dedicated to publishing original, high-quality research findings in the field of gastrointestinal oncology, including clinical, translational, and basic studies, as well as research involving artificial intelligence. The journal focuses on, but is not limited to, the following areas: Islet cell adenoma, liver cell adenoma, adenomatous polyposis coli, appendiceal neoplasms, bile duct neoplasms, biliary tract neoplasms, hepatocellular carcinoma, islet cell carcinoma, pancreatic ductal carcinoma, cecal neoplasms, colonic neoplasms, colorectal neoplasms, hereditary nonpolyposis colorectal neoplasms, common bile duct neoplasms, duodenal neoplasms, esophageal neoplasms, gallbladder neoplasms, Gardner syndrome, gastrinoma, gastrointestinal neoplasms, glucagonoma, ileal neoplasms, insulinoma, intestinal neoplasms, jejunal neoplasms, liver neoplasms, experimental liver neoplasms, pancreatic neoplasms, peritoneal neoplasms, rectal neoplasms, sigmoid neoplasms, somatostatinoma, stomach neoplasms, and vipoma. Types of articles published by the journal include clinical study, basic study, case report, editorial, review, minireview, systematic review, meta-analysis, guidelines, and correspondence. All submissions undergo a rigorous and transparent peer-review process by at least two independent reviewers. Manuscripts are evaluated based on scientific rigor, originality, clinical relevance, and reproducibility, with particular attention to methodological robustness and data integrity. Constructive and timely feedback is provided to ensure the highest standards of scholarly communication. The journal adheres to the highest standards of publication ethics and editorial integrity, in accordance with the guidelines of the Committee on Publication Ethics, the International Committee of Medical Journal Editors, and the World Association of Medical Editors. To advance scientific discovery, promote evidence-based clinical practice, and foster innovation in gastrointestinal oncology, ultimately improving global health outcomes. We invite researchers, clinicians, and multidisciplinary experts worldwide to submit high-quality manuscripts and contribute to shaping the future of gastrointestinal oncological science. Submit an Article >>

2026 Published Issues

5 4 3 2 1

Editors-in-Chief

Winnie Yeo, FRCP, FRCPE, MD, Professor, (E-mail: winnie@clo.cuhk.edu.hk) Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China

Indexing/Abstracting

The WJGO is now abstracted and indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, also known as SciSearch®), Journal Citation Reports/Science Edition, Scopus, Reference Citation Analysis, China Science and Technology Journal Database, and Superstar Journals Database.

Journal Metrics

The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJGO as 2.5; JIF without journal self cites: 2.4; 5-year JIF: 2.7; JIF Rank: 68/147 in gastroenterology and hepatology; JIF Quartile: Q2; and 5-year JIF Quartile: Q3; JIF Rank: 188/326 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.

The WJGO’s CiteScore for 2024 is 3.3 and Scopus CiteScore rank 2024: Gastroenterology is 89/173; Oncology is 235/415.

ISSN

1948-5204 (online)

Latest Manuscript Statistics

Received (4393), Duration of Peer Review (23 days/Mean), Days from Submission to First Decision (45 days/Mean), Second Decision Time (35 days/Mean), Accepted (49.6%/Mean), Production Time (53 days/Mean), Time to Publication (163 days/Mean), and Rejected (41.5%/Mean).

Current Issue

Other Issues: Previous | Next | Latest | Archive | Download full issue 5 (17)

Contents Volume 18 Issue 5 May 15, 2026

Editorial

From bile acids to yes-associated protein: A bidirectional switch for cholangiocarcinoma therapy

Shu-Yuan Zhang, Hui Yu, Yin Mi, Fan-Kai Xiao

World J Gastrointest Oncol 18(5):117990. Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117990